Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-23
2011-08-23
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000
Reexamination Certificate
active
08003600
ABSTRACT:
It has been found that high amounts of aspartate equivalents in combination with vitamin B12 and/or biotin, especially in relative absence of glutamate equivalents, improve the metabolism of ketobodies and/or lactate in a mammal's body, especially in diseased or traumatic conditions. As a result, levels of ketobodies and lactate can be decreased and unphysicologically high acidity normalized. Thus, it is an object of the invention to provide an enteral nutritional or a pharmaceutical composition for the treatment and/or prevention of disturbed ketone and lactate metabolism, i.e. elevated concentrations of ketone bodies, lactate and/or other organic acids and/or insufficient pH homeostasis, especially elevated concentrations of ketone bodies and/or lactate, in a mammal's blood, wherein the composition comprises high amounts of aspartate equivalents in combination with vitamin B12 and/or biotin, preferably in relative absence of glutamate equivalents.
REFERENCES:
patent: 4138498 (1979-02-01), Das et al.
patent: 5550146 (1996-08-01), Acosta et al.
patent: 0 957 692 (1999-11-01), None
patent: WO 98/31241 (1998-07-01), None
patent: WO 03/037378 (2003-05-01), None
patent: WO 03/037378 (2003-05-01), None
patent: WO 03/105605 (2003-12-01), None
patent: WO 2004/023891 (2004-03-01), None
Database Medline ′Online! US National Library of Medicine (NLM), Feb. 2004, Hou Jia-woei: “Biotin responsive multiple carboxylase deficiency presenting as diabetic ketoacidosis,” XP002367079.
Nosadine, R. et al, “A possible mechanism for the anti-ketogenic action of alanine in the rat.” Biochem. J. (1980), 190-323-332.
Englyst and Cummings, Adv. Exp. Med. Biol. 270-225 (1990).
Foley & Lardner LLP
N.V. Nutricia
Talapatra Sunit
Tate Christopher R.
Teller Roy
LandOfFree
Preparation for use of aspartate and vitamin B12 or biotin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation for use of aspartate and vitamin B12 or biotin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation for use of aspartate and vitamin B12 or biotin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2633290